CovidChloroV1, Main, Corpus, bibRecord, 000B39

Coronavirus Disease 2019 Related Clinical Studies: A Cross-Sectional Analysis.

Identifieur interne : 000B39 ( Main/Corpus ); précédent : 000B38; suivant : 000B40

Coronavirus Disease 2019 Related Clinical Studies: A Cross-Sectional Analysis.

Auteurs : Lin-Lu Ma ; Xuan Yin ; Bing-Hui Li ; Jia-Yu Yang ; Ying-Hui Jin ; Di Huang ; Tong Deng ; Yun-Yun Wang ; Xue-Qun Ren ; Jianguang Ji ; Xian-Tao Zeng

Source :

Frontiers in pharmacology [ 1663-9812 ] ; 2020.

RBID : pubmed:32982751

Abstract

Objective

The quality and rationality of many recently registered clinical studies related to coronavirus disease 2019 (COVID-19) needs to be assessed. Hence, this study aims to evaluate the current status of COVID-19 related registered clinical trial.

Methods

We did an electronic search of COVID-19 related clinical studies registered between December 1, 2019 and February 21, 2020 (updated to May 28, 2020) from the

Results

A total of 1,706 studies were included 10.0% of which (n=171) were from France, 943 (55.3%) used an interventional design, and 600 (35.2%) used an observational design. Most of studies (73.6%) aimed to recruit fewer than 500 people. Interferon was the main prevention program, and antiviral drugs were the main treatment program. Hydroxychloroquine and chloroquine (230/943, 24.4%) were widely studied. Some registered clinical trials are incomplete in content, and 37.4% of the 1,706 studies may have had insufficient sample size.

Conclusion

The quality of COVID-19 related studies needs to be improved by strengthening the registration process and improving the quality of clinical study protocols so that these clinical studies can provide high-quality clinical evidence related to COVID-19.

DOI: 10.3389/fphar.2020.540187
PubMed: 32982751
PubMed Central: PMC7492524

Links to Exploration step

pubmed:32982751

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Coronavirus Disease 2019 Related Clinical Studies: A Cross-Sectional Analysis.</title>
<author><name sortKey="Ma, Lin Lu" sort="Ma, Lin Lu" uniqKey="Ma L" first="Lin-Lu" last="Ma">Lin-Lu Ma</name>
<affiliation><nlm:affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yin, Xuan" sort="Yin, Xuan" uniqKey="Yin X" first="Xuan" last="Yin">Xuan Yin</name>
<affiliation><nlm:affiliation>Department of Rehabilitation, Taihe Hospital, Hubei University of Medicine, Shiyan, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Li, Bing Hui" sort="Li, Bing Hui" uniqKey="Li B" first="Bing-Hui" last="Li">Bing-Hui Li</name>
<affiliation><nlm:affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Institutes of Evidence-Based Medicine and Knowledge Translation, Henan University, Kaifeng, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yang, Jia Yu" sort="Yang, Jia Yu" uniqKey="Yang J" first="Jia-Yu" last="Yang">Jia-Yu Yang</name>
<affiliation><nlm:affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Administrative Office of Hospital Director, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Jin, Ying Hui" sort="Jin, Ying Hui" uniqKey="Jin Y" first="Ying-Hui" last="Jin">Ying-Hui Jin</name>
<affiliation><nlm:affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Huang, Di" sort="Huang, Di" uniqKey="Huang D" first="Di" last="Huang">Di Huang</name>
<affiliation><nlm:affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Deng, Tong" sort="Deng, Tong" uniqKey="Deng T" first="Tong" last="Deng">Tong Deng</name>
<affiliation><nlm:affiliation>Institutes of Evidence-Based Medicine and Knowledge Translation, Henan University, Kaifeng, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, Yun Yun" sort="Wang, Yun Yun" uniqKey="Wang Y" first="Yun-Yun" last="Wang">Yun-Yun Wang</name>
<affiliation><nlm:affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ren, Xue Qun" sort="Ren, Xue Qun" uniqKey="Ren X" first="Xue-Qun" last="Ren">Xue-Qun Ren</name>
<affiliation><nlm:affiliation>Institutes of Evidence-Based Medicine and Knowledge Translation, Henan University, Kaifeng, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ji, Jianguang" sort="Ji, Jianguang" uniqKey="Ji J" first="Jianguang" last="Ji">Jianguang Ji</name>
<affiliation><nlm:affiliation>Center for Primary Health Care Research, Lund University/Region Skåne, Malmö, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zeng, Xian Tao" sort="Zeng, Xian Tao" uniqKey="Zeng X" first="Xian-Tao" last="Zeng">Xian-Tao Zeng</name>
<affiliation><nlm:affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32982751</idno>
<idno type="pmid">32982751</idno>
<idno type="doi">10.3389/fphar.2020.540187</idno>
<idno type="pmc">PMC7492524</idno>
<idno type="wicri:Area/Main/Corpus">000B39</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000B39</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Coronavirus Disease 2019 Related Clinical Studies: A Cross-Sectional Analysis.</title>
<author><name sortKey="Ma, Lin Lu" sort="Ma, Lin Lu" uniqKey="Ma L" first="Lin-Lu" last="Ma">Lin-Lu Ma</name>
<affiliation><nlm:affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yin, Xuan" sort="Yin, Xuan" uniqKey="Yin X" first="Xuan" last="Yin">Xuan Yin</name>
<affiliation><nlm:affiliation>Department of Rehabilitation, Taihe Hospital, Hubei University of Medicine, Shiyan, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Li, Bing Hui" sort="Li, Bing Hui" uniqKey="Li B" first="Bing-Hui" last="Li">Bing-Hui Li</name>
<affiliation><nlm:affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Institutes of Evidence-Based Medicine and Knowledge Translation, Henan University, Kaifeng, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Yang, Jia Yu" sort="Yang, Jia Yu" uniqKey="Yang J" first="Jia-Yu" last="Yang">Jia-Yu Yang</name>
<affiliation><nlm:affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation>
</affiliation>
<affiliation><nlm:affiliation>Administrative Office of Hospital Director, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Jin, Ying Hui" sort="Jin, Ying Hui" uniqKey="Jin Y" first="Ying-Hui" last="Jin">Ying-Hui Jin</name>
<affiliation><nlm:affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Huang, Di" sort="Huang, Di" uniqKey="Huang D" first="Di" last="Huang">Di Huang</name>
<affiliation><nlm:affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Deng, Tong" sort="Deng, Tong" uniqKey="Deng T" first="Tong" last="Deng">Tong Deng</name>
<affiliation><nlm:affiliation>Institutes of Evidence-Based Medicine and Knowledge Translation, Henan University, Kaifeng, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wang, Yun Yun" sort="Wang, Yun Yun" uniqKey="Wang Y" first="Yun-Yun" last="Wang">Yun-Yun Wang</name>
<affiliation><nlm:affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ren, Xue Qun" sort="Ren, Xue Qun" uniqKey="Ren X" first="Xue-Qun" last="Ren">Xue-Qun Ren</name>
<affiliation><nlm:affiliation>Institutes of Evidence-Based Medicine and Knowledge Translation, Henan University, Kaifeng, China.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Ji, Jianguang" sort="Ji, Jianguang" uniqKey="Ji J" first="Jianguang" last="Ji">Jianguang Ji</name>
<affiliation><nlm:affiliation>Center for Primary Health Care Research, Lund University/Region Skåne, Malmö, Sweden.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Zeng, Xian Tao" sort="Zeng, Xian Tao" uniqKey="Zeng X" first="Xian-Tao" last="Zeng">Xian-Tao Zeng</name>
<affiliation><nlm:affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Frontiers in pharmacology</title>
<idno type="ISSN">1663-9812</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>Objective</b>
</p>
<p>The quality and rationality of many recently registered clinical studies related to coronavirus disease 2019 (COVID-19) needs to be assessed. Hence, this study aims to evaluate the current status of COVID-19 related registered clinical trial.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>Methods</b>
</p>
<p>We did an electronic search of COVID-19 related clinical studies registered between December 1, 2019 and February 21, 2020 (updated to May 28, 2020) from the </p>
</div>
<div type="abstract" xml:lang="en"><p><b>Results</b>
</p>
<p>A total of 1,706 studies were included 10.0% of which (n=171) were from France, 943 (55.3%) used an interventional design, and 600 (35.2%) used an observational design. Most of studies (73.6%) aimed to recruit fewer than 500 people. Interferon was the main prevention program, and antiviral drugs were the main treatment program. Hydroxychloroquine and chloroquine (230/943, 24.4%) were widely studied. Some registered clinical trials are incomplete in content, and 37.4% of the 1,706 studies may have had insufficient sample size.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>Conclusion</b>
</p>
<p>The quality of COVID-19 related studies needs to be improved by strengthening the registration process and improving the quality of clinical study protocols so that these clinical studies can provide high-quality clinical evidence related to COVID-19.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32982751</PMID>
<DateRevised><Year>2020</Year>
<Month>10</Month>
<Day>01</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1663-9812</ISSN>
<JournalIssue CitedMedium="Print"><Volume>11</Volume>
<PubDate><Year>2020</Year>
</PubDate>
</JournalIssue>
<Title>Frontiers in pharmacology</Title>
<ISOAbbreviation>Front Pharmacol</ISOAbbreviation>
</Journal>
<ArticleTitle>Coronavirus Disease 2019 Related Clinical Studies: A Cross-Sectional Analysis.</ArticleTitle>
<Pagination><MedlinePgn>540187</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.3389/fphar.2020.540187</ELocationID>
<Abstract><AbstractText Label="Objective" NlmCategory="UNASSIGNED">The quality and rationality of many recently registered clinical studies related to coronavirus disease 2019 (COVID-19) needs to be assessed. Hence, this study aims to evaluate the current status of COVID-19 related registered clinical trial.</AbstractText>
<AbstractText Label="Methods" NlmCategory="UNASSIGNED">We did an electronic search of COVID-19 related clinical studies registered between December 1, 2019 and February 21, 2020 (updated to May 28, 2020) from the <i>ClinicalTrials.gov</i>
, and collected registration information, study details, recruitment status, characteristics of the subjects, and relevant information about the trial implementation process.</AbstractText>
<AbstractText Label="Results" NlmCategory="UNASSIGNED">A total of 1,706 studies were included 10.0% of which (n=171) were from France, 943 (55.3%) used an interventional design, and 600 (35.2%) used an observational design. Most of studies (73.6%) aimed to recruit fewer than 500 people. Interferon was the main prevention program, and antiviral drugs were the main treatment program. Hydroxychloroquine and chloroquine (230/943, 24.4%) were widely studied. Some registered clinical trials are incomplete in content, and 37.4% of the 1,706 studies may have had insufficient sample size.</AbstractText>
<AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">The quality of COVID-19 related studies needs to be improved by strengthening the registration process and improving the quality of clinical study protocols so that these clinical studies can provide high-quality clinical evidence related to COVID-19.</AbstractText>
<CopyrightInformation>Copyright © 2020 Ma, Yin, Li, Yang, Jin, Huang, Deng, Wang, Ren, Ji and Zeng.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ma</LastName>
<ForeName>Lin-Lu</ForeName>
<Initials>LL</Initials>
<AffiliationInfo><Affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yin</LastName>
<ForeName>Xuan</ForeName>
<Initials>X</Initials>
<AffiliationInfo><Affiliation>Department of Rehabilitation, Taihe Hospital, Hubei University of Medicine, Shiyan, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Li</LastName>
<ForeName>Bing-Hui</ForeName>
<Initials>BH</Initials>
<AffiliationInfo><Affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Institutes of Evidence-Based Medicine and Knowledge Translation, Henan University, Kaifeng, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yang</LastName>
<ForeName>Jia-Yu</ForeName>
<Initials>JY</Initials>
<AffiliationInfo><Affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Administrative Office of Hospital Director, Zhongnan Hospital of Wuhan University, Wuhan, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Jin</LastName>
<ForeName>Ying-Hui</ForeName>
<Initials>YH</Initials>
<AffiliationInfo><Affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Huang</LastName>
<ForeName>Di</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Deng</LastName>
<ForeName>Tong</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Institutes of Evidence-Based Medicine and Knowledge Translation, Henan University, Kaifeng, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wang</LastName>
<ForeName>Yun-Yun</ForeName>
<Initials>YY</Initials>
<AffiliationInfo><Affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ren</LastName>
<ForeName>Xue-Qun</ForeName>
<Initials>XQ</Initials>
<AffiliationInfo><Affiliation>Institutes of Evidence-Based Medicine and Knowledge Translation, Henan University, Kaifeng, China.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ji</LastName>
<ForeName>Jianguang</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Center for Primary Health Care Research, Lund University/Region Skåne, Malmö, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Zeng</LastName>
<ForeName>Xian-Tao</ForeName>
<Initials>XT</Initials>
<AffiliationInfo><Affiliation>Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>09</Month>
<Day>02</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Switzerland</Country>
<MedlineTA>Front Pharmacol</MedlineTA>
<NlmUniqueID>101548923</NlmUniqueID>
<ISSNLinking>1663-9812</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ClinicalTrials.gov</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="N">clinical trial</Keyword>
<Keyword MajorTopicYN="N">coronavirus disease 2019</Keyword>
<Keyword MajorTopicYN="N">registration</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>03</Month>
<Day>04</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>08</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>9</Month>
<Day>28</Day>
<Hour>5</Hour>
<Minute>39</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>9</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>9</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32982751</ArticleId>
<ArticleId IdType="doi">10.3389/fphar.2020.540187</ArticleId>
<ArticleId IdType="pmc">PMC7492524</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Microbes Infect. 2020 Mar;22(2):74-79</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32017984</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2016 Jul 7;375(1):65-74</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27406349</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2017 Jun 19;357:j2816</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28630142</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci China Life Sci. 2020 Mar;63(3):364-374</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32048163</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Radiology. 2020 Aug;296(2):E115-E117</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32073353</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2004 Mar;10(3):290-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14981511</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Microbes Infect. 2020 Dec;9(1):382-385</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32065055</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2020 Mar;579(7798):270-273</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32015507</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Thorac Dis. 2018 Mar;10(3):2059-2069</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29707364</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 May 14;369:m1849</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32409561</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 22;395(10224):565-574</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32007145</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Antimicrob Chemother. 2020 Jul 1;75(7):1667-1670</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32196083</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mil Med Res. 2019 Dec 9;6(1):38</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31813379</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 May 22;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32445440</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Pharmacol Ther. 2017 Dec;102(6):917-923</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28891044</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2002 Feb 23;359(9307):696-700</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11879884</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Acta Paediatr. 2020 Jun;109(6):1088-1095</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32202343</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 2020 Jul;92(7):776-785</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32297988</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Public Health. 2018 Jan - Feb;11(1):9-17</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28864360</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 29;395(10225):683-684</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32122468</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Evid Based Med. 2019 Aug;12(3):218-224</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31215148</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Anesth Analg. 2015 Oct;121(4):1052-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26378705</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mil Med Res. 2020 Feb 29;7(1):7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32111253</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Jpn J Infect Dis. 2020 Jul 22;73(4):304-307</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32074516</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 May 16;395(10236):1569-1578</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32423584</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Glob Health Res Policy. 2019 May 20;4:13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31139753</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Korean Med Sci. 2020 Feb 17;35(6):e79</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32056407</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2020 Jun 30;117(26):14857-14863</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32527856</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2002 Feb 16;359(9306):614-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11867132</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Netw Open. 2020 Apr 24;3(4):e208857</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32330277</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31986264</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mil Med Res. 2020 Feb 6;7(1):4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32029004</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Jul 28;71(15):841-843</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32047895</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Glob Health Res Policy. 2020 Jul 1;5:33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32617414</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Allergy. 2020 Jul;75(7):1730-1741</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32077115</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Med Virol. 2020 Feb 27;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32104917</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Jun 9;323(22):2262-2263</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32364561</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Jul 17;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32678530</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ Open. 2020 Jun 9;10(6):e039978</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32518212</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>RNA. 2020 Jul;26(7):771-783</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32358057</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Chem. 2020 Apr 1;66(4):549-555</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32031583</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Jul;56(1):105949</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Am J Med Sci. 2013 Dec;5(12):713-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24404555</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B39 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000B39 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32982751
   |texte=   Coronavirus Disease 2019 Related Clinical Studies: A Cross-Sectional Analysis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i   -Sk "pubmed:32982751" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidChloroV1

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021

	Serveur d'exploration COVID et hydrochloroquine
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration COVID et hydrochloroquine

Coronavirus Disease 2019 Related Clinical Studies: A Cross-Sectional Analysis.

Coronavirus Disease 2019 Related Clinical Studies: A Cross-Sectional Analysis.

Source :

Abstract

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki